Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals.
Ratings
1.6 / 5
7 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Jason Kelly$1.8B
Market Cap • 24/04/20242008
(há 16 anos)
2021
(3 years ago)
NYSE
Listagem
Boston
Sede • Massachusetts1.292
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
DNASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.